{"store":{"baseInfo":{"podcastTitle":"The HemOnc Pulse","slug":"hemoncpulse","podcastDescription":"Blood Cancers Today and the Society of Hematologic Oncology bring you The HemOnc Pulse, a podcast hosted by Chadi Nabhan, MD, MBA, FACP, covering all topics in the world of hematologic oncology.","podcastLogo":"https://pbcdn1.podbean.com/imglogo/image-logo/17871411/Podcast_logo-3_6hhvaf.png","podcastShareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/image-logo/17871411/Podcast_logo-3_6hhvaf_1200x628.jpg?s=b2f90d5a2a686a372fe1e58f8df3c232&e=png","podcastUrl":"https://hemoncpulse.podbean.com","podcastCanSearched":true,"feedUrl":"https://feed.podbean.com/hemoncpulse/feed.xml","theme":"elegant","podcastDeepLink":"https://www.podbean.com/pu/pbblog-gbcct-110b233","removePodbeanBranding":"no","brandingLogo":null,"timeZone":{"timeZoneId":15,"gmtAdjustment":"GMT-05:00","useDaylightTime":1,"value":-5,"text":"(GMT-05:00) Eastern Time (US & Canada)","daylightStartTime":"Second Sunday Of March +2 Hours","daylightEndTime":"First Sunday Of November +2 Hours","timezone":"America/New_York"},"podcastDownloads":null,"totalEpisodes":59,"showComments":true,"iOSAppDownloadLink":null,"customizeCssUrl":null,"androidAppDownloadLink":null,"showPostShare":true,"showLike":true,"author":"Chadi Nabhan, MD, MBA, FACP","engagementStatsBaseUrl":null,"shareEmbedLink":"https://admin5.podbean.com/embed.html?id=pbblog-gbcct-110b233-playlist","language":"en","sensitivitySessionExpireTime":3600,"podcastApps":[{"name":"Podbean App","link":"https://r4j68.app.goo.gl/?link=https%3A%2F%2Fhemoncpulse.podbean.com%3Faction%3DopenPodcast%26podcastId%3Dpbblog17871411%26podcastIdTag%3Dgbcct&dfl=https%3A%2F%2Fhemoncpulse.podbean.com&utm_campaign=pb_web&utm_source=podbean_web&utm_medium=dlink&imv=670&amv=530&isi=973361050&ibi=com.podbean.app.podcast&ipbi=com.podbean.app.podcast&apn=com.podbean.app.podcast","image":"https://pbcdn1.podbean.com/fs1/site/images/admin5/podbean-app.png","title":null}],"components":{"base":[{"id":"MainStyle","val":"light"},{"id":"Font","val":"Avenir"},{"id":"SecondaryFont","val":"Avenir"},{"id":"PlayerColor","val":"#8fc31f"},{"id":"PlayerStyle","val":"player1"},{"id":"PlayerWave","val":"show"},{"id":"Favicon","val":null},{"id":"CookiesNotice","val":"hide"},{"id":"CookiesNoticeContent","val":"

Cookies Notice

This website uses cookies to improve your experience while you navigate through the website. By using our website you agree to our use of cookies.

"}],"home-header":[{"id":"HomeHeaderTextColor","val":"#000000"},{"id":"HomeHeaderBackgroundColor","val":"#ffffff"}],"page-header":[{"id":"PageHeaderTextColor","val":"#ffffff"},{"id":"PageHeaderBackgroundColor","val":"#868686"}],"episode-list":[{"id":"EpisodeListType","val":"grid"},{"id":"EpisodesPerPage","val":10},{"id":"EpisodeStats","val":"show"}],"navigation":[{"id":"NavigationFontColor","val":"#000000"},{"id":"NavigationBackgroundColor","val":"#e9e9e9"},{"id":"NavigationSearch","val":"show"},{"id":"NavigationLinks","val":[{"id":"Home","type":"Link","value":"/","text":"Home","subitems":[]},{"id":"Subscribe","type":"Link","value":"https://www.podbean.com/site/podcatcher/index/blog/r1zV1nCvRuqN","text":"Subscribe","subitems":[]},{"id":"Profile","type":"Link","value":"https://www.podbean.com/user-W6nWPbI0puz9","text":"Profile","subitems":[]}]}],"footer":[{"id":"FooterType","val":"Footer2"},{"id":"FooterFontColor","val":"#ffffff"},{"id":"FooterBackgroundColor","val":"#000000"},{"id":"FooterCopyright","val":"Copyright 2024 All rights reserved."},{"id":"SocialMediaLinks","val":{"facebook_username":"","twitter_username":"","instagram_username":"","youtube_username":"","linkedin_username":""}}],"customize-container1":[],"customize-container2":[{"id":"ComponentImageText-1","val":{"ComponentFontColor":"#000000","ComponentBackgroundColor":"#f2f2f2","ComponentImage":"/assets/customize-component1.png","ComponentContent":"

Your Title

This is the description area. You can write an introduction or add anything you want to tell your audience. This can help potential listeners better understand and become interested in your podcast. Think about what will motivate them to hit the play button. What is your podcast about? What makes it unique? This is your chance to introduce your podcast and grab their attention.

"}}]},"allLinks":[],"mainStylesDefaultSettings":null,"defaultCustomizeComponents":null,"scripts":[],"metas":null,"appConfig":{"package":"com.podbean.app.podcast","app_store_id":973361050,"app_name":"Podbean","scheme":"podbean"},"customizeCss":null,"canEditCss":null,"enableJsCodeInCustomizeContent":false,"enabledIframeCodeInCustomizeContent":true,"sectionMaxCount":10,"enableEditorLink":true,"enableEditCookiesNotice":true,"siteRedirectToFeed":false,"podcatcherRssUrl":null,"showFeed":true,"showTopBar":true,"enableWebSiteLike":null,"organizationName":null,"organizationPageLink":null},"backToListUrl":"/","tinymceLoaded":false,"listEpisodes":[],"userLikedEpisodes":[],"topBarIframeLoaded":false,"listTotalCount":0,"listTotalPage":0,"listPage":0,"listType":"all","listValue":"","listName":"","pageLoading":false,"apiBaseUrl":"https://hemoncpulse.podbean.com","apiCommonParams":{"t":"674168a3","clientSignature":"54df456a50f8472af53ab9f9db2c2766","u":null,"customizing":null},"apiCommonHeaders":{},"comments":[],"commentsTotalCount":0,"commentsTotalPage":0,"commentsPage":1,"commentEpisodeId":"pb22486080-nkc28","episode":{"id":"pb22486080","idTag":"nkc28","title":"Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17_1200x628.jpg?s=c84e44a52353331bac668eb66d464c98&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17.jpg","previewContent":null,"content":"In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma.","publishTimestamp":1678363200,"duration":2120,"mediaUrl":"https://mcdn.podbean.com/mf/web/ao6xnz/track_1C7F3G_http___feeds_soundcloud_com_stream_1464411541-blood-cancers-today-graham-collins-md-on-navigating-the-latest-research-in-hodgkin-lymphoma.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-nkc28-1571c40","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-nkc28-1571c40","transcriptUrl":null,"permalink":"/e/graham-collins-mbbs-on-new-agents-prognostic-models-in-hodgkin-lymphoma/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB1571C40NKC28","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":21,"status":"publish","hasMoreContent":false,"chaptersUrl":null},"episodeShareLink":null,"deepLink":"https://www.podbean.com/ew/pb-nkc28-1571c40","playlist":{"episodes":[],"current":0,"start":0,"stop":0,"playing":true,"playerLoading":true,"playbackRate":1,"playbackRateIndex":1},"toasts":[],"confirm":null,"customizeEditorFormZIndex":999,"lastRequestTime":null,"validateChangesOnBeforeunload":true,"windowWidth":1000,"VITE_FS1_CDN_URL_PREFIX":"https://pbcdn1.podbean.com/fs1","reloadStats":false},"episode":{"id":"pb22486080","idTag":"nkc28","title":"Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma","logo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17_300x300.jpg","shareLogo":"https://d2bwo9zemjwxh5.cloudfront.net/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17_1200x628.jpg?s=c84e44a52353331bac668eb66d464c98&e=jpg","largeLogo":"https://pbcdn1.podbean.com/imglogo/ep-logo/pbblog17871411/d6e288bee30e8d4041989888d1682f17.jpg","previewContent":null,"content":"In the latest episode of The HemOnc Pulse, Graham Collins, MBBS, MA, MRCP, FRCPath, DPhil, a lymphoma specialist at Oxford Cancer and Haematology Centre, discusses the findings from the HoLISTIC Consortium, and what he thinks about checkpoint inhibitors upfront in the treatment of Hodgkin lymphoma.","publishTimestamp":1678363200,"duration":2120,"mediaUrl":"https://mcdn.podbean.com/mf/web/ao6xnz/track_1C7F3G_http___feeds_soundcloud_com_stream_1464411541-blood-cancers-today-graham-collins-md-on-navigating-the-latest-research-in-hodgkin-lymphoma.mp3","mediaType":"audio/mpeg","shareLink":"https://admin5.podbean.com/embed.html?id=pb-nkc28-1571c40","likedCount":0,"deepLink":"https://www.podbean.com/ew/pb-nkc28-1571c40","transcriptUrl":null,"permalink":"/e/graham-collins-mbbs-on-new-agents-prognostic-models-in-hodgkin-lymphoma/","downloadLink":"https://www.podbean.com/site/EpisodeDownload/PB1571C40NKC28","fallbackResource":null,"fallbackResourceMimetype":null,"downloadCount":21,"status":"publish","hasMoreContent":false,"chaptersUrl":null}}

Graham Collins, MBBS, on New Agents, Prognostic Models in Hodgkin Lymphoma

Comments (0)